Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain B, pheromone binding protein | 0 | 0 | 1 | 1 |
Chain A, pheromone binding protein | 0 | 0 | 1 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 13 | 0 | 0 | 13 |
Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
acid sphingomyelinase | 4 | 0 | 0 | 4 |
thioredoxin reductase | 47 | 0 | 0 | 47 |
USP1 protein, partial | 42 | 0 | 0 | 42 |
TDP1 protein | 78 | 0 | 0 | 78 |
vitamin D3 receptor isoform VDRA | 31 | 0 | 0 | 31 |
importin subunit beta-1 isoform 1 | 10 | 0 | 0 | 10 |
flap endonuclease 1 | 20 | 0 | 0 | 20 |
serine/threonine-protein kinase PLK1 | 6 | 0 | 0 | 6 |
snurportin-1 | 10 | 0 | 0 | 10 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 12 | 0 | 0 | 12 |
GTP-binding nuclear protein Ran isoform 1 | 9 | 0 | 0 | 9 |
DNA polymerase eta isoform 1 | 6 | 0 | 0 | 6 |
DNA polymerase iota isoform a (long) | 31 | 0 | 0 | 31 |
urokinase-type plasminogen activator precursor | 14 | 0 | 0 | 14 |
plasminogen precursor | 14 | 0 | 0 | 14 |
urokinase plasminogen activator surface receptor precursor | 14 | 0 | 0 | 14 |
geminin | 74 | 0 | 0 | 74 |
DNA polymerase kappa isoform 1 | 25 | 0 | 0 | 25 |
fibroblast growth factor 22 isoform 1 precursor | 0 | 0 | 0 | 1 |
Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 3 | 0 | 3 |
Transthyretin | 0 | 2 | 7 | 14 |
Fatty acid-binding protein, intestinal | 0 | 8 | 2 | 10 |
Fatty acid-binding protein, adipocyte | 0 | 2 | 2 | 4 |
Cyclin-A2 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 2 | 1 | 3 |
Cyclin-dependent kinase 2 | 0 | 2 | 1 | 3 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 9 | 0 | 0 | 9 |
Fatty acid-binding protein 5 | 0 | 1 | 1 | 2 |
Fatty acid-binding protein 5 | 0 | 0 | 2 | 2 |
Mitogen-activated protein kinase 11 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 5 | 0 | 5 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 47 | 0 | 0 | 47 |
aldehyde dehydrogenase 1 family, member A1 | 65 | 0 | 0 | 65 |
glucocorticoid receptor [Homo sapiens] | 71 | 0 | 0 | 71 |
farnesoid X nuclear receptor | 40 | 0 | 0 | 40 |
estrogen nuclear receptor alpha | 117 | 0 | 0 | 117 |
Voltage-dependent calcium channel gamma-2 subunit | 38 | 0 | 0 | 38 |
Cellular tumor antigen p53 | 62 | 0 | 0 | 62 |
Glutamate receptor 2 | 39 | 3 | 1 | 43 |
Choline O-acetyltransferase | 0 | 2 | 0 | 4 |
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1 | 0 | 1 | 0 | 1 |
Chain A, Proto-oncogene serine/threonine-protein kinase Pim-1 | 0 | 1 | 0 | 1 |
Chain A, HADH2 protein | 33 | 0 | 0 | 33 |
Chain B, HADH2 protein | 33 | 0 | 0 | 33 |
Chain A, 2-oxoglutarate Oxygenase | 39 | 0 | 0 | 39 |
Chain A, Cruzipain | 19 | 0 | 0 | 19 |
Chain A, Methyltransferase Wbdd | 0 | 1 | 0 | 1 |
15-lipoxygenase, partial | 23 | 0 | 0 | 23 |
ATAD5 protein, partial | 30 | 0 | 0 | 30 |
NFKB1 protein, partial | 16 | 0 | 0 | 16 |
Thrombopoietin | 6 | 0 | 0 | 6 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 24 | 0 | 0 | 24 |
thyroid stimulating hormone receptor | 42 | 0 | 0 | 42 |
regulator of G-protein signaling 4 | 33 | 0 | 0 | 33 |
EWS/FLI fusion protein | 38 | 0 | 0 | 39 |
67.9K protein | 18 | 0 | 0 | 18 |
Parkin | 12 | 0 | 0 | 12 |
euchromatic histone-lysine N-methyltransferase 2 | 79 | 0 | 0 | 79 |
cytochrome P450 2D6 isoform 1 | 17 | 0 | 0 | 17 |
cellular tumor antigen p53 isoform a | 14 | 0 | 0 | 14 |
cytochrome P450 2C19 precursor | 18 | 0 | 0 | 18 |
cytochrome P450 2C9 precursor | 18 | 0 | 0 | 18 |
chromobox protein homolog 1 | 45 | 0 | 0 | 45 |
serine/threonine-protein kinase mTOR isoform 1 | 8 | 0 | 0 | 8 |
survival motor neuron protein isoform d | 31 | 0 | 0 | 31 |
cytochrome P450 3A4 isoform 1 | 42 | 0 | 0 | 42 |
M-phase phosphoprotein 8 | 13 | 0 | 0 | 13 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 0 | 1 | 0 | 2 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 3 | 0 | 3 |
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase PLK4 | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 42 | 12 | 6 | 60 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 16 | 1 | 0 | 17 |
Bromodomain-containing protein 4 | 0 | 1 | 1 | 2 |
5-hydroxytryptamine receptor 4 | 0 | 14 | 0 | 14 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 4 | 0 | 4 |
Integrin beta-3 | 12 | 1 | 1 | 14 |
Cytochrome P450 1A2 | 0 | 15 | 0 | 19 |
Integrin alpha-IIb | 12 | 1 | 1 | 14 |
Neuronal acetylcholine receptor subunit alpha-4 | 4 | 6 | 0 | 10 |
Serine/threonine-protein kinase pim-1 | 0 | 2 | 1 | 3 |
Neuronal acetylcholine receptor subunit beta-2 | 4 | 6 | 0 | 10 |
Gamma-aminobutyric acid receptor subunit beta-1 | 42 | 12 | 6 | 60 |
Gamma-aminobutyric acid receptor subunit delta | 42 | 12 | 6 | 60 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 42 | 13 | 7 | 62 |
Casein kinase II subunit alpha' | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 42 | 13 | 6 | 61 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 42 | 12 | 6 | 60 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 42 | 12 | 6 | 60 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 42 | 12 | 6 | 60 |
Proteinase-activated receptor 1 | 0 | 1 | 1 | 3 |
Bromodomain-containing protein 2 | 0 | 3 | 0 | 3 |
Phosphatidylinositol 3-kinase regulatory subunit alpha | 0 | 2 | 0 | 3 |
5-hydroxytryptamine receptor 2A | 0 | 14 | 1 | 15 |
5-hydroxytryptamine receptor 2C | 0 | 15 | 1 | 16 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 42 | 12 | 6 | 60 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 42 | 12 | 6 | 60 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 42 | 12 | 6 | 60 |
Sodium-dependent serotonin transporter | 0 | 12 | 0 | 13 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Type-1 angiotensin II receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 18 | 1 | 19 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 0 | 2 | 0 | 3 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0 | 1 | 0 | 3 |
Serine/threonine-protein kinase mTOR | 0 | 2 | 0 | 2 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 27 | 3 | 1 | 33 |
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 3 | 0 | 4 |
Glycogen synthase kinase-3 beta | 0 | 4 | 0 | 4 |
D(1A) dopamine receptor | 5 | 2 | 0 | 7 |
Serine/threonine-protein kinase PLK1 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 42 | 13 | 7 | 62 |
Gamma-aminobutyric acid receptor subunit beta-3 | 42 | 13 | 6 | 61 |
Gamma-aminobutyric acid receptor subunit beta-2 | 42 | 12 | 7 | 61 |
Casein kinase II subunit beta | 0 | 3 | 0 | 3 |
Casein kinase II subunit alpha | 0 | 3 | 0 | 3 |
DNA-dependent protein kinase catalytic subunit | 0 | 3 | 0 | 3 |
Mu-type opioid receptor | 0 | 5 | 1 | 6 |
Serine-protein kinase ATM | 0 | 2 | 0 | 2 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase B | 0 | 3 | 0 | 3 |
Serine/threonine-protein kinase ATR | 0 | 2 | 0 | 2 |
cGMP-inhibited 3',5'-cyclic phosphodiesterase A | 0 | 4 | 0 | 4 |
Bromodomain-containing protein 3 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase pim-3 | 0 | 1 | 0 | 1 |
Phosphoinositide 3-kinase regulatory subunit 5 | 0 | 1 | 0 | 1 |
GABA theta subunit | 42 | 12 | 6 | 60 |
Gamma-aminobutyric acid receptor subunit epsilon | 42 | 12 | 6 | 60 |
Serine/threonine-protein kinase PLK3 | 0 | 2 | 0 | 2 |
Serine/threonine-protein kinase PLK2 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 35 | 0 | 0 | 35 |
Monocarboxylate transporter 4 | 0 | 0 | 0 | 1 |
Monocarboxylate transporter 1 | 0 | 1 | 0 | 2 |
Monocarboxylate transporter 2 | 0 | 2 | 0 | 2 |
hypoxia-inducible factor 1 alpha subunit | 23 | 0 | 0 | 23 |
RAR-related orphan receptor gamma | 66 | 0 | 0 | 66 |
GLI family zinc finger 3 | 75 | 0 | 0 | 75 |
AR protein | 98 | 0 | 0 | 98 |
retinoic acid nuclear receptor alpha variant 1 | 65 | 0 | 0 | 65 |
retinoid X nuclear receptor alpha | 56 | 0 | 0 | 56 |
peroxisome proliferator-activated receptor delta | 43 | 0 | 0 | 43 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 50 | 0 | 0 | 50 |
activating transcription factor 6 | 29 | 0 | 0 | 29 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 32 | 0 | 0 | 32 |
Histone H2A.x | 24 | 0 | 0 | 24 |
thyroid hormone receptor beta isoform a | 35 | 0 | 0 | 35 |
heat shock protein beta-1 | 24 | 0 | 0 | 24 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 71 | 0 | 0 | 71 |
lamin isoform A-delta10 | 72 | 0 | 0 | 72 |
Kynureninase | 0 | 0 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 7 | 0 | 7 |
5-hydroxytryptamine receptor 2C | 0 | 11 | 2 | 13 |
5-hydroxytryptamine receptor 2A | 0 | 10 | 2 | 12 |
5-hydroxytryptamine receptor 1A | 0 | 22 | 6 | 30 |
5-hydroxytryptamine receptor 1B | 0 | 16 | 2 | 18 |
5-hydroxytryptamine receptor 1D | 0 | 6 | 2 | 8 |
5-hydroxytryptamine receptor 1F | 0 | 6 | 2 | 8 |
5-hydroxytryptamine receptor 2B | 0 | 10 | 2 | 12 |
5-hydroxytryptamine receptor 6 | 0 | 2 | 2 | 4 |
Sodium-dependent serotonin transporter | 0 | 18 | 1 | 19 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 2 | 5 |
5-hydroxytryptamine receptor 5A | 0 | 2 | 2 | 4 |
5-hydroxytryptamine receptor 5B | 0 | 2 | 2 | 4 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 2 | 4 |
5-hydroxytryptamine receptor 4 | 0 | 2 | 2 | 4 |
5-hydroxytryptamine receptor 3B | 0 | 2 | 2 | 4 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 19 | 0 | 0 | 19 |
Luciferase | 37 | 0 | 0 | 37 |
phosphopantetheinyl transferase | 36 | 0 | 0 | 36 |
SMAD family member 2 | 29 | 0 | 0 | 29 |
SMAD family member 3 | 29 | 0 | 0 | 29 |
peroxisome proliferator activated receptor gamma | 53 | 0 | 0 | 53 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 49 | 0 | 0 | 49 |
pyruvate kinase PKM isoform a | 2 | 0 | 0 | 2 |
Lactoylglutathione lyase | 0 | 10 | 0 | 10 |
TAR DNA-binding protein 43 | 24 | 0 | 0 | 24 |
GLS protein | 30 | 0 | 0 | 30 |
Microtubule-associated protein tau | 38 | 0 | 0 | 39 |
Smad3 | 12 | 0 | 0 | 12 |
nuclear receptor subfamily 1, group I, member 3 | 49 | 0 | 0 | 49 |
progesterone receptor | 49 | 0 | 0 | 49 |
estrogen-related nuclear receptor alpha | 77 | 0 | 0 | 77 |
aryl hydrocarbon receptor | 36 | 0 | 0 | 36 |
thyroid hormone receptor beta isoform 2 | 65 | 0 | 0 | 65 |
peripheral myelin protein 22 | 32 | 0 | 0 | 32 |
ATP-binding cassette sub-family C member 3 | 0 | 55 | 0 | 55 |
Multidrug resistance-associated protein 4 | 0 | 56 | 0 | 58 |
Solute carrier family 22 member 6 | 0 | 17 | 0 | 17 |
Carbonic anhydrase 12 | 0 | 10 | 1 | 14 |
UDP-glucuronosyltransferase 1A9 | 0 | 2 | 1 | 9 |
Bile salt export pump | 0 | 13 | 0 | 13 |
Bile salt export pump | 0 | 81 | 0 | 81 |
Cytochrome P450 2B1 | 0 | 1 | 0 | 2 |
Cytochrome P450 1A1 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 1 | 0 | 24 | 1 | 33 |
Carbonic anhydrase 2 | 0 | 24 | 1 | 32 |
Myoglobin | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 6 | 2 | 9 |
Prostaglandin G/H synthase 1 | 0 | 25 | 1 | 27 |
Carbonic anhydrase 3 | 0 | 10 | 1 | 13 |
Cytochrome P450 3A4 | 0 | 25 | 1 | 30 |
Cytochrome P450 2D6 | 0 | 22 | 0 | 22 |
Cytochrome P450 2C9 | 0 | 33 | 1 | 36 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 5 | 0 | 5 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 2 |
UDP-glucuronosyltransferase 1-6 | 0 | 4 | 1 | 7 |
Arachidonate 5-lipoxygenase-activating protein | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A1 | 0 | 5 | 1 | 10 |
Carbonic anhydrase 4 | 0 | 12 | 1 | 15 |
Prostaglandin G/H synthase 1 | 0 | 23 | 0 | 23 |
Carbonic anhydrase 6 | 0 | 11 | 1 | 14 |
Carbonic anhydrase 5A, mitochondrial | 0 | 11 | 1 | 15 |
Prostaglandin G/H synthase 2 | 0 | 28 | 2 | 32 |
Carbonic anhydrase 7 | 0 | 10 | 1 | 13 |
Nuclear receptor ROR-gamma | 19 | 0 | 0 | 19 |
Cytochrome P450 2J2 | 0 | 18 | 0 | 18 |
Carbonic anhydrase 9 | 0 | 12 | 1 | 16 |
Canalicular multispecific organic anion transporter 1 | 0 | 51 | 0 | 51 |
Carbonic anhydrase 15 | 0 | 7 | 0 | 8 |
Carbonic anhydrase 13 | 0 | 8 | 0 | 10 |
Carbonic anhydrase 14 | 0 | 10 | 1 | 14 |
Carbonic anhydrase 5B, mitochondrial | 0 | 10 | 1 | 14 |
toxin B | 0 | 0 | 0 | 1 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 26 | 0 | 0 | 26 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Carbonic Anhydrase Ii | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 20 | 0 | 0 | 20 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Endochitinase | 0 | 1 | 0 | 1 |
Chain A, Class Iii Chitinase Chia1 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 13 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase II | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain B, Carbonic anhydrase | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
GALC protein | 7 | 0 | 0 | 7 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 45 | 0 | 0 | 45 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
arylsulfatase A | 28 | 0 | 0 | 28 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Bloom syndrome protein isoform 1 | 36 | 0 | 0 | 36 |
muscleblind-like protein 1 isoform 1 | 18 | 0 | 0 | 18 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Prolyl endopeptidase | 0 | 1 | 0 | 1 |
Carbonic anhydrase-related protein 11 | 0 | 1 | 0 | 2 |
Glycogen phosphorylase, muscle form | 0 | 2 | 0 | 2 |
Renin | 0 | 3 | 0 | 3 |
Carbonic anhydrase 2 | 0 | 2 | 0 | 2 |
Cathepsin B | 0 | 1 | 0 | 1 |
Steryl-sulfatase | 0 | 1 | 0 | 2 |
Cytochrome P450 2C8 | 0 | 4 | 0 | 4 |
Cytochrome P450 2A6 | 0 | 2 | 0 | 2 |
Androgen receptor | 0 | 16 | 0 | 16 |
Translocator protein | 0 | 2 | 2 | 5 |
Cytochrome P450 2B6 | 0 | 2 | 2 | 4 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 10 | 0 | 11 |
Serum paraoxonase/arylesterase 1 | 0 | 5 | 0 | 5 |
Dipeptidyl peptidase 4 | 0 | 3 | 0 | 4 |
Endochitinase | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 9 | 0 | 11 |
Delta-type opioid receptor | 0 | 3 | 0 | 4 |
Cytochrome P450 2C19 | 0 | 11 | 0 | 12 |
Delta-type opioid receptor | 0 | 6 | 1 | 8 |
Mu-type opioid receptor | 0 | 7 | 1 | 11 |
Carbonic anhydrase | 0 | 3 | 0 | 3 |
Kappa-type opioid receptor | 0 | 6 | 2 | 8 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 7 | 2 | 9 |
Cholinesterase | 0 | 5 | 0 | 5 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Fatty-acid amide hydrolase 1 | 1 | 5 | 0 | 6 |
Beta-carbonic anhydrase 1 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 9 | 1 | 10 |
Squalene synthase | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 4 | 0 | 4 |
Carbonic anhydrase | 0 | 4 | 0 | 4 |
Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 2 | 0 | 2 |
Carbonic anhydrase 3 | 0 | 4 | 0 | 4 |
Carbonic anhydrase | 0 | 1 | 0 | 2 |
Carbonic anhydrase | 0 | 2 | 0 | 3 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 4 | 0 | 4 |
Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 1 | 4 |
Renin | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Endochitinase A1 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 5 | 1 | 7 |
Carbonic anhydrase 4 | 0 | 3 | 0 | 4 |
Acidic mammalian chitinase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 7 | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2, isoform A | 0 | 1 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 9 | 0 | 0 | 9 |
acetylcholinesterase | 23 | 0 | 0 | 23 |
dopamine D1 receptor | 4 | 0 | 0 | 4 |
pregnane X receptor | 13 | 0 | 0 | 13 |
D(1A) dopamine receptor | 14 | 0 | 0 | 14 |
muscarinic acetylcholine receptor M1 | 23 | 0 | 0 | 23 |
Histone deacetylase 3 | 0 | 3 | 0 | 3 |
Histone deacetylase 4 | 0 | 3 | 0 | 3 |
Histone deacetylase 1 | 0 | 5 | 0 | 5 |
Histone deacetylase 7 | 0 | 3 | 0 | 3 |
Histone deacetylase 2 | 0 | 5 | 0 | 5 |
Polyamine deacetylase HDAC10 | 0 | 3 | 0 | 3 |
Histone deacetylase 11 | 0 | 3 | 0 | 3 |
Ataxin-2 | 31 | 0 | 0 | 31 |
Histone deacetylase 8 | 0 | 4 | 0 | 4 |
Histone deacetylase 6 | 0 | 4 | 0 | 4 |
Histone deacetylase 9 | 0 | 3 | 0 | 3 |
Histone deacetylase 5 | 0 | 3 | 0 | 3 |
RGS12 | 1 | 0 | 0 | 1 |
estrogen receptor 2 (ER beta) | 38 | 0 | 0 | 38 |
Alpha-synuclein | 7 | 5 | 1 | 13 |
interleukin 8 | 15 | 0 | 0 | 15 |
IDH1 | 24 | 0 | 0 | 24 |
transcriptional regulator ERG isoform 3 | 6 | 0 | 0 | 6 |
ras-related protein Rab-9A | 14 | 0 | 0 | 14 |
Polyphenol oxidase 2 | 0 | 7 | 0 | 11 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 0 | 0 | 1 |
Xanthine dehydrogenase/oxidase [Includes: Xanthine dehydrogenase | 0 | 1 | 0 | 1 |
Adenosine receptor A2a | 0 | 11 | 3 | 15 |
Xanthine dehydrogenase/oxidase | 0 | 5 | 0 | 5 |
Nuclear receptor ROR-gamma | 0 | 1 | 0 | 1 |
Xanthine dehydrogenase/oxidase | 0 | 5 | 1 | 8 |
Purine nucleoside phosphorylase | 0 | 0 | 1 | 1 |
Shiga toxin subunit A | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 2 |
thyroid stimulating hormone receptor | 23 | 0 | 0 | 23 |
Heat shock protein HSP 90-alpha | 0 | 0 | 1 | 1 |
Botulinum neurotoxin type A | 0 | 1 | 0 | 1 |
Neutrophil cytosol factor 1 | 0 | 2 | 0 | 2 |
Nitric oxide synthase, endothelial | 0 | 1 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 1 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 1 | 1 | 4 |
Phosphatidylinositol 4-kinase alpha | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase | 0 | 0 | 1 | 1 |
Phosphatidylinositol 4-kinase type 2-beta | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase type 2-alpha | 0 | 1 | 0 | 1 |
Phosphatidylinositol 4-kinase beta | 0 | 1 | 0 | 1 |
pregnane X nuclear receptor | 63 | 0 | 0 | 63 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 27 | 0 | 0 | 27 |
nuclear receptor ROR-gamma isoform 1 | 36 | 0 | 0 | 36 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 8 | 7 | 15 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 8 | 5 | 13 |
Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 7 | 6 | 13 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 7 | 5 | 12 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 7 | 4 | 11 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 7 | 4 | 11 |
Cholecystokinin receptor type A | 0 | 2 | 0 | 2 |
ATPase family AAA domain-containing protein 5 | 23 | 0 | 0 | 23 |
signal transducer and activator of transcription 6, interleukin-4 induced | 2 | 0 | 0 | 2 |
putative alpha-glucosidase | 1 | 0 | 0 | 1 |
histone acetyltransferase KAT2A isoform 1 | 20 | 0 | 0 | 20 |
Solute carrier family 22 member 2 | 0 | 6 | 0 | 9 |
Solute carrier family 22 member 1 | 0 | 15 | 0 | 19 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 2 | 0 | 2 |
Matrix protein 2 | 0 | 1 | 1 | 2 |
Matrix protein 2 | 0 | 1 | 2 | 3 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 8 | 1 | 9 |
Spike glycoprotein | 32 | 0 | 2 | 34 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 8 | 1 | 9 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 8 | 1 | 9 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 8 | 1 | 9 |
Solute carrier family 22 member 1 | 0 | 8 | 0 | 10 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 8 | 1 | 9 |
Multidrug and toxin extrusion protein 1 | 0 | 13 | 0 | 13 |
Solute carrier family 22 member 2 | 0 | 8 | 0 | 9 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 8 | 1 | 9 |
Chain U, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
Chain A, UROKINASE-TYPE PLASMINOGEN ACTIVATOR | 0 | 1 | 0 | 1 |
glucocerebrosidase | 17 | 0 | 0 | 17 |
alpha-galactosidase | 8 | 0 | 0 | 8 |
lysosomal alpha-glucosidase preproprotein | 11 | 0 | 0 | 11 |
huntingtin isoform 2 | 8 | 0 | 0 | 8 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 3 | 3 | 6 |
Coagulation factor X | 0 | 3 | 0 | 3 |
Plasminogen | 0 | 5 | 2 | 7 |
Urokinase-type plasminogen activator | 0 | 4 | 0 | 4 |
Tissue-type plasminogen activator | 0 | 2 | 0 | 2 |
Cationic trypsin | 0 | 2 | 0 | 2 |
Coagulation factor XI | 0 | 1 | 0 | 1 |
Plasma kallikrein | 0 | 1 | 0 | 1 |
Vitamin K-dependent protein C | 0 | 1 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 2 | 0 | 2 |
Trypsin-1 | 0 | 2 | 0 | 2 |
Trypsin-2 | 0 | 2 | 0 | 2 |
Sodium/hydrogen exchanger 1 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 9 | 0 | 9 |
Sodium/hydrogen exchanger 1 | 0 | 3 | 0 | 3 |
Sodium/hydrogen exchanger 3 | 0 | 2 | 0 | 2 |
Trypsin-3 | 0 | 2 | 0 | 2 |
Amiloride-sensitive sodium channel subunit alpha | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 9 | 0 | 9 |
Sodium/hydrogen exchanger 2 | 0 | 2 | 0 | 2 |
Acid-sensing ion channel 1 | 0 | 3 | 0 | 3 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 24 | 0 | 25 |
Sodium channel protein type 5 subunit alpha | 0 | 7 | 0 | 7 |
Sodium/hydrogen exchanger 5 | 0 | 2 | 0 | 2 |
Acid-sensing ion channel 3 | 0 | 1 | 0 | 1 |
Sodium/hydrogen exchanger | 0 | 1 | 0 | 1 |
Chain A, PLASMINOGEN | 0 | 0 | 2 | 2 |
Chain A, PLASMINOGEN | 0 | 0 | 2 | 2 |
Chain A, Ferritin light chain | 17 | 0 | 0 | 17 |
Chain A, Apolipoprotein | 0 | 0 | 1 | 1 |
nonstructural protein 1 | 13 | 0 | 0 | 13 |
Rap guanine nucleotide exchange factor 3 | 4 | 0 | 0 | 4 |
Proton-coupled amino acid transporter 1 | 0 | 7 | 0 | 8 |
Solute carrier family 22 member 3 | 0 | 1 | 0 | 1 |
Phenylethanolamine N-methyltransferase | 0 | 2 | 0 | 2 |
Substance-P receptor | 0 | 3 | 0 | 3 |
Cytochrome P450 2A5 | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 9 | 0 | 9 |
Beta-2 adrenergic receptor | 0 | 3 | 3 | 7 |
Sigma non-opioid intracellular receptor 1 | 0 | 5 | 2 | 7 |
tumor necrosis factor | 2 | 0 | 0 | 2 |
Aurora kinase B | 0 | 2 | 0 | 2 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 6 | 1 | 8 |
Chain A, Mutant Al2 6e7p9g | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
apical membrane antigen 1, AMA1 | 5 | 0 | 0 | 5 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase type 2 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-11 | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase VIM-2 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
DNA polymerase beta | 12 | 0 | 0 | 12 |
60 kDa heat shock protein, mitochondrial | 0 | 8 | 0 | 8 |
Beta-lactamase OXA-7 | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 4 | 0 | 4 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
10 kDa heat shock protein, mitochondrial | 0 | 8 | 0 | 8 |
Angiopoietin-1 receptor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 1 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 8 | 0 | 8 |
Metallo-beta-lactamase VIM-13 | 0 | 0 | 0 | 1 |
Efflux transporter | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase Toho-1 | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Class D beta-lactamase | 0 | 0 | 0 | 2 |
60 kDa chaperonin | 0 | 8 | 0 | 8 |
Metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Solute carrier family 15 member 2 | 0 | 2 | 0 | 2 |
Beta-lactamase | 0 | 0 | 0 | 1 |
Beta-lactamase | 0 | 0 | 0 | 1 |
10 kDa chaperonin | 0 | 8 | 0 | 8 |
Metallo-b-lactamase | 0 | 0 | 0 | 3 |
Carbapenem-hydrolyzing beta-lactamase KPC | 0 | 0 | 0 | 1 |
Beta-lactamase class B VIM-2 | 0 | 0 | 0 | 3 |
Beta-lactamase VIM-1 | 0 | 0 | 0 | 1 |
Estrogen receptor | 0 | 7 | 2 | 9 |
Sex hormone-binding globulin | 0 | 0 | 7 | 7 |
Corticosteroid-binding globulin | 0 | 7 | 0 | 8 |
Androgen receptor | 0 | 7 | 2 | 9 |
Estrogen receptor beta | 0 | 5 | 2 | 7 |
Caspase-7 | 8 | 0 | 0 | 8 |
peripheral myelin protein 22 isoform 1 | 19 | 0 | 0 | 19 |
potassium voltage-gated channel subfamily H member 2 isoform d | 20 | 0 | 0 | 20 |
caspase-3 | 8 | 0 | 0 | 8 |
mitogen-activated protein kinase 1 | 21 | 0 | 0 | 21 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 4 | 0 | 2 | 6 |
neuropeptide S receptor isoform A | 11 | 0 | 0 | 11 |
Beta-glucuronidase | 0 | 2 | 0 | 2 |
Cholinesterase | 0 | 9 | 0 | 9 |
Aromatase | 0 | 11 | 0 | 13 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 2 |
Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 29 | 0 | 0 | 29 |
Nicotinate phosphoribosyltransferase | 0 | 7 | 0 | 7 |
Chain A, ADIPOCYTE LIPID-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
Chain A, SERUM ALBUMIN | 0 | 0 | 1 | 1 |
thioredoxin glutathione reductase | 12 | 0 | 0 | 12 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 11 | 0 | 0 | 11 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 10 | 0 | 0 | 10 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 6 | 0 | 0 | 6 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 5 | 2 | 0 | 7 |
caspase-1 isoform alpha precursor | 5 | 0 | 0 | 5 |
Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 1 | 0 | 7 | 0 | 9 |
Trypsin | 0 | 2 | 0 | 3 |
Coagulation factor VII | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 5 | 0 | 5 |
Tissue factor | 0 | 3 | 0 | 3 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Calmodulin | 0 | 0 | 0 | 1 |
Disintegrin and metalloproteinase domain-containing protein 17 | 9 | 0 | 0 | 9 |
Prostaglandin G/H synthase 2 | 0 | 15 | 0 | 16 |
Solute carrier organic anion transporter family member 2A1 | 0 | 1 | 0 | 3 |
Lanosterol 14-alpha demethylase | 0 | 5 | 0 | 5 |
Solute carrier organic anion transporter family member 1B3 | 0 | 8 | 0 | 13 |
Cytosolic phospholipase A2 gamma | 0 | 2 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 2 | 1 | 3 |
Solute carrier organic anion transporter family member 1B1 | 0 | 9 | 0 | 14 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 2 | 2 |
lethal factor (plasmid) | 16 | 0 | 0 | 16 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 3 | 0 | 4 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
Albumin | 0 | 3 | 0 | 3 |
Urease | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
Tyrosinase | 0 | 5 | 0 | 5 |
Alpha-2B adrenergic receptor | 0 | 12 | 2 | 16 |
Hyaluronate lyase | 0 | 1 | 0 | 1 |
Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
Egl nine homolog 1 | 0 | 0 | 0 | 1 |
Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 1 | 0 | 2 |
Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
Metabotropic glutamate receptor 6 | 0 | 2 | 2 | 5 |
Excitatory amino acid transporter 4 | 0 | 2 | 0 | 2 |
Glutamate transporter homolog | 0 | 0 | 1 | 1 |
N(4)-(beta-N-acetylglucosaminyl)-L-asparaginase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 2 | 0 | 3 |
Excitatory amino acid transporter 1 | 0 | 3 | 0 | 4 |
Excitatory amino acid transporter 2 | 0 | 3 | 0 | 4 |
Excitatory amino acid transporter 3 | 0 | 3 | 0 | 4 |
Metabotropic glutamate receptor 1 | 0 | 1 | 2 | 4 |
Metabotropic glutamate receptor 2 | 0 | 1 | 2 | 4 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 3 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
GTP-binding protein (rab7) | 0 | 0 | 2 | 2 |
ras protein, partial | 0 | 0 | 2 | 2 |
hypothetical protein, conserved | 4 | 0 | 0 | 4 |
cytochrome P450 2D6 | 37 | 0 | 0 | 37 |
Rac1 protein | 0 | 0 | 2 | 2 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 2 | 2 |
Prostaglandin-H2 D-isomerase | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 4 | 0 | 5 |
Epidermal growth factor receptor | 0 | 9 | 0 | 9 |
Fatty acid-binding protein, liver | 0 | 9 | 0 | 9 |
Myeloperoxidase | 0 | 4 | 0 | 4 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 3 | 0 | 5 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Substance-P receptor | 0 | 7 | 0 | 7 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 2 | 0 | 2 |
Ras-related protein Rab-2A | 0 | 0 | 2 | 2 |
Rho-associated protein kinase 2 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 20 | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 6 | 0 | 4 | 0 | 4 |
Sigma non-opioid intracellular receptor 1 | 0 | 17 | 2 | 19 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 12 | 3 | 19 |
Muscarinic acetylcholine receptor M4 | 0 | 11 | 1 | 14 |
Muscarinic acetylcholine receptor M1 | 0 | 7 | 1 | 10 |
Muscarinic acetylcholine receptor M3 | 0 | 6 | 1 | 9 |
Muscarinic acetylcholine receptor M4 | 0 | 5 | 1 | 8 |
Muscarinic acetylcholine receptor M5 | 0 | 6 | 1 | 9 |
Muscarinic acetylcholine receptor M5 | 0 | 10 | 1 | 13 |
Muscarinic acetylcholine receptor M2 | 0 | 6 | 1 | 10 |
Muscarinic acetylcholine receptor M1 | 0 | 13 | 2 | 19 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 12 | 2 | 16 |
Alpha-1D adrenergic receptor | 0 | 12 | 2 | 17 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 2 | 4 |
Glucocorticoid receptor | 0 | 17 | 2 | 24 |
Progesterone receptor | 0 | 3 | 0 | 4 |
Mineralocorticoid receptor | 0 | 3 | 1 | 4 |
Chain A, Integrase | 0 | 1 | 0 | 1 |
Chain A, Integrase | 0 | 1 | 0 | 1 |
Chain A, T4 LYSOZYME | 0 | 0 | 1 | 1 |
Chain A, GCN4P1 | 0 | 0 | 1 | 1 |
Chain B, GCN4P1 | 0 | 0 | 1 | 1 |
Chain C, GCN4P1 | 0 | 0 | 1 | 1 |
Chain A, T4 LYSOZYME | 0 | 0 | 1 | 1 |
Chain A, T4 LYSOZYME | 0 | 0 | 1 | 1 |
Chain A, Replicase polyprotein 1ab | 0 | 1 | 0 | 1 |
Chain A, 3C-like proteinase | 0 | 1 | 0 | 1 |
Endolysin | 0 | 0 | 2 | 2 |
Dihydroorotate dehydrogenase | 0 | 2 | 0 | 2 |
Protease | 0 | 1 | 0 | 1 |
Chain A, Betaine ABC transporter permease and substrate binding protein | 0 | 0 | 1 | 1 |
Chain A, Osmoprotection protein (ProX) | 0 | 0 | 1 | 1 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 2 | 2 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 2 | 2 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 2 | 2 |
Chain A, Glycine betaine/carnitine/choline-binding protein | 0 | 0 | 2 | 2 |
nuclear receptor subfamily 1, group I, member 2 | 13 | 0 | 0 | 13 |
galanin receptor type 3 | 0 | 2 | 0 | 2 |
Glycine receptor subunit alpha-1 | 0 | 16 | 0 | 16 |
Glycine receptor subunit beta | 0 | 16 | 0 | 16 |
Glycine receptor subunit alpha-2 | 0 | 16 | 0 | 16 |
Glycine receptor subunit alpha-3 | 0 | 16 | 0 | 16 |
ORF73 | 0 | 0 | 2 | 2 |
Caspase-7 | 4 | 0 | 0 | 4 |
Inositol monophosphatase 1 | 9 | 0 | 0 | 9 |
Potassium channel subfamily K member 3 | 0 | 3 | 0 | 3 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 2 | 3 | 5 |
Potassium channel subfamily K member 9 | 0 | 1 | 0 | 1 |
Chain A, Glycogen Phosphorylase | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 2 | 2 |
Chain A, Chitinase | 0 | 1 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 5 | 0 | 0 | 5 |
Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 4 | 3 | 7 |
Adenosine receptor A3 | 0 | 12 | 1 | 13 |
Replicase polyprotein 1ab | 0 | 5 | 3 | 8 |
Acetylcholinesterase | 0 | 15 | 0 | 15 |
Amine oxidase [flavin-containing] B | 0 | 8 | 0 | 8 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4A | 0 | 5 | 0 | 5 |
Adenosine receptor A3 | 0 | 1 | 0 | 1 |
Adenosine receptor A2b | 0 | 2 | 0 | 3 |
Adenosine receptor A2b | 0 | 2 | 0 | 3 |
Adenosine receptor A1 | 0 | 8 | 1 | 11 |
Vasopressin V2 receptor | 0 | 0 | 0 | 1 |
Adenosine receptor A2a | 0 | 1 | 0 | 1 |
Adenosine receptor A1 | 0 | 2 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 2 | 0 | 2 |
Adenylate cyclase type 1 | 0 | 0 | 0 | 1 |
Chitotriosidase-1 | 0 | 3 | 1 | 4 |
Adenosine receptor A2b | 0 | 1 | 0 | 2 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 2 | 0 | 2 |
Palmitoleoyl-protein carboxylesterase NOTUM | 0 | 2 | 2 | 4 |
Endochitinase B1 | 0 | 3 | 1 | 4 |
Phosphodiesterase | 0 | 2 | 0 | 2 |
Guanine deaminase | 0 | 2 | 0 | 2 |
Chain A, Vitamin D Nuclear Receptor | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 0 | 1 | 1 |
PPM1D protein | 9 | 0 | 0 | 9 |
Interferon beta | 42 | 0 | 0 | 42 |
Vitamin D-binding protein | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 2 | 3 | 8 |
Vitamin D3 receptor | 0 | 1 | 1 | 3 |
Retinoic acid receptor RXR-alpha | 0 | 2 | 1 | 3 |
Vitamin D3 receptor | 0 | 0 | 2 | 2 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 1 | 1 | 2 |
Transporter | 0 | 2 | 0 | 2 |
Vitamin D3 receptor A | 0 | 0 | 2 | 2 |
transient receptor potential cation channel subfamily V member 1 | 2 | 0 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 3 | 1 | 4 |
Lysine-specific histone demethylase 1A | 0 | 7 | 0 | 7 |
NADH-ubiquinone oxidoreductase chain 1 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 3 | 0 | 3 |
Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 1 | 2 |
Corticotropin-releasing factor receptor 2 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 1 | 4 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 1 | 2 |
Vpr | 5 | 0 | 0 | 5 |
Albumin | 0 | 0 | 5 | 5 |
Major prion protein | 0 | 0 | 3 | 3 |
Sodium channel protein type 1 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 2 subunit alpha | 0 | 3 | 1 | 4 |
Sodium channel protein type 3 subunit alpha | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 2B7 | 0 | 4 | 1 | 13 |
Sodium channel protein type 4 subunit alpha | 0 | 5 | 0 | 7 |
Sodium channel protein type 9 subunit alpha | 0 | 6 | 0 | 6 |
Frizzled-8 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
Dihydroxyacetone phosphate acyltransferase | 0 | 0 | 0 | 2 |
B2 metallo-beta-lactamase | 0 | 0 | 0 | 1 |
Chain A, serum paraoxonase | 0 | 1 | 0 | 1 |
Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 0 | 1 |
caspase 7, apoptosis-related cysteine protease | 16 | 0 | 0 | 16 |
caspase-3 | 16 | 0 | 0 | 16 |
thyrotropin-releasing hormone receptor | 6 | 0 | 0 | 6 |
Caspase-2 | 0 | 0 | 1 | 1 |
G | 31 | 0 | 0 | 31 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 23 | 0 | 0 | 23 |
streptokinase A precursor | 0 | 0 | 3 | 3 |
HLA class I histocompatibility antigen, B alpha chain | 31 | 0 | 0 | 31 |
30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 31 | 0 | 0 | 31 |
Methionine--tRNA ligase, mitochondrial | 0 | 0 | 1 | 1 |
cytochrome P450 2C9, partial | 31 | 0 | 0 | 31 |
PINK1 | 3 | 0 | 0 | 3 |
bromodomain adjacent to zinc finger domain 2B | 11 | 0 | 0 | 11 |
serine-protein kinase ATM isoform a | 1 | 0 | 0 | 1 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 5 | 0 | 0 | 5 |
prostaglandin E2 receptor EP2 subtype | 0 | 0 | 0 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 4 | 7 | 0 | 0 | 7 |
Glycine receptor subunit alpha-1 | 0 | 0 | 2 | 2 |
Chain A, Acetylcholinesterase | 0 | 0 | 2 | 2 |
Chain A, Acetylcholinesterase | 0 | 0 | 2 | 2 |
Chain A, Acetylcholinesterase | 0 | 0 | 2 | 2 |
Chain A, Acetylcholinesterase | 0 | 0 | 2 | 2 |
Chain A, Acetylcholinesterase | 0 | 0 | 2 | 2 |
Chain A, Acetylcholinesterase | 0 | 0 | 2 | 2 |
Chain A, Acetylcholinesterase | 0 | 0 | 2 | 2 |
Chain A, Putative Glycine Betaine-binding Abc Transporter Protein | 0 | 0 | 1 | 1 |
Chain A, PUTATIVE GLYCINE BETAINE-BINDING ABC TRANSPORTER PROTEIN | 0 | 0 | 1 | 1 |
Chain A, Choline-binding protein | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
Neuronal acetylcholine receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-4 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-9 | 0 | 1 | 0 | 1 |
High affinity choline transporter 1 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-10 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 6 | 0 | 6 |
ATP-dependent translocase ABCB1 | 0 | 17 | 1 | 26 |
Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 6 | 0 | 6 |
Histamine H2 receptor | 0 | 8 | 0 | 8 |
Histamine H1 receptor | 0 | 0 | 2 | 2 |
Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
Aldehyde oxidase | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 6 | 0 | 13 | 0 | 14 |
Multidrug and toxin extrusion protein 2 | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 8 | 0 | 9 | 0 | 10 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 11 | 0 | 2 | 0 | 3 |
Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 2 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
DNA gyrase subunit A | 0 | 2 | 0 | 5 |
DNA gyrase subunit B | 0 | 2 | 0 | 5 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 2 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 2 |
DNA topoisomerase 2-alpha | 0 | 1 | 0 | 4 |
DNA gyrase subunit A | 0 | 1 | 0 | 2 |
Multidrug resistance protein MdtK | 0 | 0 | 1 | 1 |
DNA gyrase subunit B | 0 | 3 | 0 | 4 |
DNA gyrase subunit A | 0 | 4 | 0 | 5 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 2 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA topoisomerase 4 subunit B | 0 | 1 | 0 | 1 |
Integrase | 0 | 2 | 0 | 2 |
Chain A, CHIMERA OF IG KAPPA CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain B, CHIMERA OF IG GAMMA-1 CHAIN: HUMAN CONSTANT REGION AND MOUSE VARIABLE REGION | 0 | 0 | 1 | 1 |
Chain H, Fab M82G2, Heavy chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82G2, Light chain | 0 | 0 | 1 | 1 |
Chain H, Fab M82g2, Heavy Chain | 0 | 0 | 1 | 1 |
Chain L, Fab M82g2, Light Chain | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 6 | 0 | 6 |
Amyloid-beta precursor protein | 0 | 8 | 1 | 10 |
Fatty acid-binding protein, heart | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M2 | 0 | 1 | 0 | 1 |
Tryptophan 5-hydroxylase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 6 | 2 | 8 |
D | 0 | 5 | 0 | 5 |
Alpha-2B adrenergic receptor | 0 | 7 | 2 | 9 |
Alpha-2C adrenergic receptor | 0 | 7 | 2 | 9 |
Alpha-2A adrenergic receptor | 0 | 7 | 2 | 9 |
Liver carboxylesterase 1 | 0 | 0 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 22 | 1 | 23 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 7 | 4 | 11 |
Lysosomal Pro-X carboxypeptidase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 6 | 2 | 8 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 6 | 0 | 6 |
Sodium-dependent dopamine transporter | 0 | 17 | 0 | 17 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 3 | 0 | 4 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 0 | 4 | 0 | 4 |
Leukotriene B4 receptor 1 | 1 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 6 | 2 | 8 |
Sodium-dependent dopamine transporter | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 6 | 0 | 6 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 6 | 0 | 6 |
Leukotriene B4 receptor 2 | 1 | 1 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 6 | 0 | 6 |
Transporter | 0 | 5 | 0 | 5 |
Cytochrome P450 2D1 | 0 | 2 | 0 | 2 |
Cytochrome P450 2D26 | 0 | 2 | 0 | 2 |
Cytochrome P450 2D3 | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 3 | 2 | 6 |
Mu-type opioid receptor | 0 | 15 | 5 | 21 |
Delta-type opioid receptor | 0 | 7 | 3 | 11 |
Kappa-type opioid receptor | 0 | 12 | 3 | 16 |
Mu-type opioid receptor | 0 | 3 | 2 | 7 |
Cytochrome P450 2D4 | 0 | 2 | 0 | 2 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 5 | 5 |
endonuclease IV | 6 | 0 | 0 | 6 |
Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
Chain A, Breast cancer type 1 susceptibility protein | 2 | 0 | 0 | 2 |
Nrf2 | 4 | 0 | 0 | 4 |
alkaline phosphatase, intestinal | 0 | 1 | 0 | 1 |
toll-like receptor 9 | 0 | 1 | 0 | 1 |
TPA: protein transporter TIM10 | 0 | 1 | 0 | 1 |
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 1 | 0 | 1 |
hemoglobin subunit beta | 2 | 0 | 0 | 2 |
perilipin-5 | 0 | 1 | 0 | 1 |
intestinal alkaline phosphatase precursor | 0 | 1 | 0 | 1 |
perilipin-1 | 0 | 1 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 7 | 0 | 0 | 7 |
tumor susceptibility gene 101 protein | 2 | 0 | 0 | 2 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
alkaline phosphatase, germ cell type preproprotein | 0 | 1 | 0 | 1 |
hypothetical protein SA1422 | 0 | 1 | 0 | 1 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 1 | 0 | 0 | 1 |
Prostaglandin E synthase | 0 | 3 | 0 | 3 |
Acetylcholinesterase | 0 | 6 | 0 | 6 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
Phospholipase A2 | 0 | 2 | 0 | 2 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 3 | 0 | 3 |
Neuronal proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Heme oxygenase 1 | 0 | 2 | 0 | 2 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Microtubule-associated protein tau | 0 | 1 | 0 | 2 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 18 | 2 | 20 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 2 | 0 | 2 |
Glycogen synthase kinase-3 beta | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Heme oxygenase 2 | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 9 | 2 | 11 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
Proteasome subunit beta type-5 | 0 | 2 | 0 | 2 |
17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 18 | 2 | 20 |
Beta-secretase 1 | 0 | 3 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Histone acetyltransferase p300 | 0 | 2 | 0 | 2 |
Serine/threonine-protein kinase PAK 1 | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 1 | 2 |
Sodium/bile acid cotransporter | 0 | 2 | 1 | 3 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 2 | 4 |
Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 1 |
Thioredoxin reductase 3 | 0 | 1 | 0 | 1 |
Sortase A | 0 | 1 | 0 | 1 |
CREB-binding protein | 1 | 2 | 0 | 3 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | 0 | 2 | 0 | 2 |
Cysteine protease | 0 | 1 | 0 | 1 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
Thioredoxin reductase 2, mitochondrial | 0 | 1 | 0 | 1 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 4 | 0 | 4 |
Lymphocyte antigen 96 | 0 | 0 | 1 | 1 |
Beta lactamase (plasmid) | 0 | 2 | 0 | 2 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 5 | 0 | 5 |
G-protein coupled bile acid receptor 1 | 0 | 0 | 2 | 2 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
NPC1-like intracellular cholesterol transporter 1 | 0 | 0 | 1 | 1 |
Solute carrier organic anion transporter family member 1A4 | 0 | 4 | 0 | 6 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 2 |
Multidrug resistance-associated protein 1 | 0 | 2 | 0 | 3 |
Solute carrier organic anion transporter family member 1A1 | 0 | 3 | 0 | 4 |
Solute carrier organic anion transporter family member 1A2 | 0 | 1 | 0 | 3 |
Solute carrier organic anion transporter family member 1A3 | 0 | 3 | 0 | 5 |
ATP-binding cassette sub-family C member 11 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
Vascular endothelial growth factor receptor 2 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid | 0 | 1 | 1 | 2 |
glp-1 receptor, partial | 22 | 0 | 0 | 22 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 6 | 0 | 6 |
Alpha-1-acid glycoprotein 1 | 0 | 0 | 0 | 1 |
Albumin | 0 | 13 | 10 | 24 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 4 | 0 | 5 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 1 | 2 |
Translocator protein | 0 | 1 | 0 | 1 |
Translocator protein | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 1 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 6 | 0 | 6 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 6 | 0 | 6 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 9 | 0 | 9 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 1 | 2 |
Sphingosine-1-phosphate lyase 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 1 | 2 |
Aldo-keto reductase family 1 member B10 | 0 | 3 | 0 | 3 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 1 | 4 | 5 |
Dihydrofolate reductase | 0 | 6 | 0 | 6 |
Cytochrome c oxidase subunit 2 | 0 | 3 | 0 | 3 |
Interleukin-8 | 0 | 3 | 0 | 3 |
Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 9 | 0 | 9 |
UDP-glucuronosyltransferase 1A4 | 0 | 3 | 1 | 8 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 5 | 0 | 5 |
C-X-C chemokine receptor type 1 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 5 | 0 | 5 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 5 | 0 | 5 |
Prostaglandin G/H synthase 2 | 0 | 8 | 0 | 10 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 1 | 7 |
UDP-glucuronosyltransferase 2B10 | 0 | 3 | 1 | 4 |
Sodium- and chloride-dependent betaine transporter | 0 | 5 | 0 | 5 |
Prostaglandin G/H synthase 2 | 0 | 5 | 0 | 6 |
Prostaglandin G/H synthase 1 | 0 | 9 | 0 | 11 |
P2Y purinoceptor 12 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A7 | 0 | 1 | 1 | 3 |
UDP-glucuronosyltransferase 1A10 | 0 | 1 | 1 | 2 |
electroneutral potassium-chloride cotransporter KCC2 | 0 | 0 | 1 | 1 |
High mobility group protein B1 | 0 | 0 | 2 | 2 |
2-amino-3-carboxymuconate-6-semialdehyde decarboxylase | 0 | 2 | 0 | 2 |
STAT3, partial | 0 | 1 | 0 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 8 | 0 | 0 | 8 |
signal transducer and activator of transcription 1-alpha/beta isoform alpha | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-2 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-2 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-1 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit beta-3 | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit gamma | 0 | 1 | 0 | 1 |
Sodium/potassium-transporting ATPase subunit alpha-4 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 1 | 0 | 2 |
Cereblon isoform 4 | 0 | 4 | 0 | 4 |
Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
Protein cereblon | 0 | 6 | 1 | 8 |
replicative DNA helicase | 0 | 0 | 0 | 1 |
recombinase A | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 2B17 | 0 | 0 | 1 | 2 |
Chain A, Protein (peroxisome Proliferator Activated Receptor (ppar-delta)) | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 6 | 6 |
Oxoeicosanoid receptor 1 | 0 | 1 | 0 | 1 |
Adenylate cyclase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Lck | 0 | 3 | 0 | 3 |
Tyrosine-protein kinase Fyn | 0 | 3 | 0 | 3 |
Beta-2 adrenergic receptor | 0 | 10 | 2 | 12 |
Beta-1 adrenergic receptor | 0 | 12 | 2 | 14 |
Alpha-2A adrenergic receptor | 0 | 13 | 3 | 18 |
D(2) dopamine receptor | 0 | 11 | 2 | 15 |
Alpha-2C adrenergic receptor | 0 | 10 | 2 | 14 |
D(1A) dopamine receptor | 0 | 9 | 1 | 11 |
Thromboxane-A synthase | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 1B | 0 | 4 | 1 | 5 |
D(3) dopamine receptor | 0 | 11 | 1 | 14 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 8 | 1 | 9 |
Fumarate hydratase | 9 | 0 | 0 | 9 |
polyprotein | 9 | 0 | 0 | 9 |
Aldo-keto reductase family 1 member B1 | 0 | 18 | 0 | 18 |
3-oxo-5-alpha-steroid 4-dehydrogenase 1 | 0 | 2 | 0 | 2 |
Sulfotransferase 1A1 | 0 | 2 | 1 | 4 |
Nuclear receptor subfamily 1 group I member 3 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily KQT member 3 | 0 | 0 | 2 | 5 |
Potassium voltage-gated channel subfamily KQT member 2 | 0 | 0 | 2 | 5 |
UDP-glucuronosyltransferase 2B11 | 0 | 0 | 1 | 1 |
Potassium voltage-gated channel subfamily KQT member 2 | 0 | 0 | 1 | 1 |
Potassium voltage-gated channel subfamily KQT member 3 | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 2B4 | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 2A1 | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 2A2 | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 1A5 | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 2B15 | 0 | 0 | 1 | 1 |
Potassium voltage-gated channel subfamily KQT member 4 | 0 | 0 | 1 | 2 |
UDP-glucuronosyltransferase 2A3 | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 2B28 | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 1 | 2 |
Potassium voltage-gated channel subfamily KQT member 5 | 0 | 0 | 1 | 3 |
Potassium voltage-gated channel subfamily KQT member 2 | 0 | 0 | 1 | 1 |
histone deacetylase 9 isoform 3 | 13 | 0 | 0 | 13 |
Caspase-1 | 0 | 7 | 0 | 8 |
Caspase-3 | 0 | 6 | 0 | 6 |
Caspase-4 | 0 | 6 | 0 | 6 |
Caspase-5 | 0 | 6 | 0 | 6 |
Caspase-9 | 0 | 6 | 0 | 6 |
Prostaglandin D2 receptor 2 | 0 | 2 | 1 | 3 |
Chain A, PROTEIN (TRANSTHYRETIN) | 0 | 0 | 1 | 1 |
Chain B, PROTEIN (TRANSTHYRETIN) | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily M member 2 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C4 | 0 | 5 | 0 | 5 |
Aldo-keto reductase family 1 member C3 | 0 | 8 | 0 | 8 |
Transcription factor SOX-18 | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member C2 | 0 | 5 | 0 | 5 |
Aldo-keto reductase family 1 member C1 | 0 | 5 | 0 | 5 |
Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
Transcriptional enhancer factor TEF-3 | 0 | 1 | 1 | 2 |
Potassium channel subfamily K member 18 | 0 | 1 | 1 | 2 |
Acid-sensing ion channel 5 | 0 | 0 | 1 | 1 |
hexokinase-4 isoform 1 | 3 | 0 | 0 | 3 |
glucokinase regulatory protein | 3 | 0 | 0 | 3 |
eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
Serine hydroxymethyltransferase, mitochondrial | 0 | 2 | 0 | 2 |
Single-stranded DNA cytosine deaminase | 2 | 0 | 0 | 2 |
phosphoglycerate kinase | 3 | 0 | 0 | 3 |
Acid-sensing ion channel 3 | 0 | 2 | 0 | 2 |
Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Thymidylate synthase | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 2 | 1 | 3 |
Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
Multidrug resistance associated protein | 0 | 0 | 0 | 1 |
Corticosteroid 11-beta-dehydrogenase isozyme 1 | 0 | 1 | 0 | 1 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Holo-[acyl-carrier-protein] synthase | 0 | 1 | 0 | 1 |
G-protein coupled receptor 35 | 0 | 2 | 2 | 4 |
Voltage-dependent calcium channel subunit alpha-2/delta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit rho-3 | 0 | 0 | 1 | 1 |
Hsf1 protein | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid type B receptor subunit 2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit rho-1 | 0 | 0 | 2 | 2 |
Gamma-aminobutyric acid receptor subunit rho-2 | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent taurine transporter | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 0 | 0 | 1 |
Sterol O-acyltransferase 1 | 0 | 0 | 1 | 1 |
Platelet glycoprotein VI | 0 | 0 | 1 | 1 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid type B receptor subunit 1 | 0 | 1 | 0 | 1 |
beta-amyloid peptide, A beta {N-terminal} [human, cerebrospinal fluid, conditioned medium of mixed-brain cell cultures, Peptide Partial, 33 aa] | 1 | 0 | 0 | 1 |
alpha synuclein, partial | 1 | 0 | 0 | 1 |
luciferase | 2 | 0 | 0 | 2 |
Substance-K receptor | 0 | 8 | 0 | 8 |
Glutamate receptor ionotropic, kainate 1 | 1 | 2 | 1 | 4 |
Glutamate receptor ionotropic, kainate 2 | 1 | 2 | 1 | 4 |
Glutamate receptor ionotropic, kainate 3 | 1 | 2 | 0 | 3 |
Glutamate receptor ionotropic, kainate 4 | 1 | 2 | 0 | 3 |
Glutamate receptor ionotropic, kainate 5 | 1 | 2 | 0 | 3 |
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | 0 | 1 | 0 | 1 |
Chain A, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
Chain B, Glutamate Receptor Subunit 2 | 0 | 1 | 0 | 1 |
Chain A, Slr1257 protein | 0 | 0 | 1 | 1 |
Chain A, Glucosamine--fructose-6-phosphate aminotransferase [isomerizing] | 0 | 1 | 0 | 1 |
beta-2 adrenergic receptor | 2 | 0 | 0 | 2 |
Metabotropic glutamate receptor 8 | 0 | 2 | 0 | 2 |
Glutathione reductase, mitochondrial | 0 | 3 | 0 | 3 |
Bifunctional aspartokinase/homoserine dehydrogenase 1 | 0 | 1 | 0 | 1 |
ATP-citrate synthase | 0 | 1 | 0 | 1 |
Glutamate receptor 1 | 2 | 3 | 1 | 6 |
Glutamate receptor 3 | 2 | 3 | 1 | 6 |
Glutamate receptor 4 | 2 | 3 | 1 | 6 |
Metabotropic glutamate receptor 1 | 0 | 2 | 1 | 3 |
Metabotropic glutamate receptor 2 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 3 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 5 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 6 | 0 | 0 | 1 | 1 |
Metabotropic glutamate receptor 7 | 0 | 0 | 1 | 1 |
Glutamate receptor ionotropic, kainate 1 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 3 |
Glutamate receptor 1 | 0 | 2 | 1 | 3 |
Glutamate receptor 2 | 0 | 2 | 1 | 3 |
Glutamate receptor 3 | 0 | 1 | 1 | 2 |
Metabotropic glutamate receptor 8 | 0 | 0 | 1 | 1 |
Glutamate receptor 4 | 0 | 2 | 1 | 3 |
Excitatory amino acid transporter 3 | 0 | 0 | 0 | 1 |
Glutamate racemase | 0 | 0 | 0 | 1 |
Metabotropic glutamate receptor 8 | 0 | 1 | 1 | 2 |
Glutamate carboxypeptidase 2 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, kainate 2 | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, kainate 3 | 0 | 1 | 0 | 1 |
Metabotropic glutamate receptor 7 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 3 | 0 | 1 | 1 | 3 |
Metabotropic glutamate receptor 4 | 0 | 1 | 1 | 3 |
Glutamate receptor ionotropic, kainate 5 | 0 | 1 | 0 | 1 |
Glutamate racemase | 0 | 0 | 0 | 1 |
Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 1 | 0 | 1 |
Chain A, Glutamine Binding Protein | 0 | 0 | 1 | 1 |
Neutral amino acid transporter A | 0 | 2 | 0 | 2 |
Asc-type amino acid transporter 1 | 0 | 2 | 0 | 2 |
Neutral amino acid transporter B(0) | 0 | 2 | 0 | 2 |
Amino acid transporter | 0 | 2 | 0 | 2 |
Chain B, EUKARYOTIC TRANSLATION INITIATION FACTOR 4E | 0 | 0 | 1 | 1 |
Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase | 0 | 1 | 0 | 1 |
Chain A, 3-phosphoshikimate 1-carboxyvinyltransferase | 0 | 1 | 0 | 1 |
Glutamine synthetase | 0 | 1 | 0 | 1 |
Cytochrome P450 71B1 | 0 | 1 | 0 | 2 |
Glutamine synthetase | 0 | 1 | 0 | 1 |
2-dehydro-3-deoxyphosphooctonate aldolase | 0 | 1 | 0 | 1 |
Adenylate cyclase type 1 | 0 | 1 | 0 | 1 |
Cocaine esterase | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 4 | 0 | 4 |
Vitamin D-binding protein | 0 | 1 | 0 | 1 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 2 | 2 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 5 | 1 | 6 |
Beta-2 adrenergic receptor | 0 | 4 | 0 | 5 |
Angiotensin-converting enzyme | 0 | 3 | 0 | 3 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
Beta-1 adrenergic receptor | 0 | 5 | 2 | 8 |
D(3) dopamine receptor | 0 | 4 | 0 | 4 |
D(2) dopamine receptor | 0 | 2 | 0 | 2 |
D(4) dopamine receptor | 0 | 6 | 1 | 9 |
D(1B) dopamine receptor | 0 | 2 | 0 | 3 |
Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
D(1B) dopamine receptor | 0 | 3 | 0 | 3 |
Beta-3 adrenergic receptor | 0 | 3 | 0 | 3 |
Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 3 | 0 | 3 |
Histamine H1 receptor | 0 | 3 | 0 | 3 |
C-8 sterol isomerase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 1 | 4 |
Kappa-type opioid receptor | 0 | 4 | 1 | 6 |
Alpha-1A adrenergic receptor | 0 | 4 | 3 | 12 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 4 | 0 | 4 |
Alpha-1B adrenergic receptor | 0 | 3 | 2 | 8 |
Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
Sodium channel protein type 7 subunit alpha | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 1 | 0 | 1 |
Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 1 | 0 | 1 |
Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Zinc finger protein 664 | 0 | 1 | 0 | 1 |
Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
Protease | 0 | 5 | 0 | 5 |
Adenylyl cyclase 7 | 0 | 1 | 0 | 1 |
D | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 3 | 0 | 3 |
Sodium channel protein type 3 subunit alpha | 0 | 4 | 0 | 4 |
Sodium channel protein type 11 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 8 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 10 subunit alpha | 0 | 3 | 0 | 3 |
Neuraminidase | 0 | 5 | 0 | 5 |
carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | 0 | 1 | 0 | 1 |
Calmodulin-1 | 0 | 2 | 0 | 2 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Nischarin | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 3 | 0 | 3 |
Heparanase | 0 | 0 | 1 | 1 |
N(G),N(G)-dimethylarginine dimethylaminohydrolase 1 | 0 | 1 | 0 | 1 |
Glycogen synthase kinase-3 alpha | 0 | 2 | 0 | 2 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Chain A, Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
DNA polymerase III, partial | 2 | 0 | 0 | 2 |
Tyrosinase | 0 | 3 | 0 | 3 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 2 | 0 | 2 |
large T antigen | 0 | 3 | 0 | 3 |
Geranylgeranyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
Farnesyl pyrophosphate synthase | 0 | 4 | 0 | 4 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 7 | 0 | 11 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP1 subtype | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP2 subtype | 0 | 0 | 1 | 1 |
Prostacyclin receptor | 0 | 2 | 1 | 3 |
Prostacyclin receptor | 0 | 1 | 1 | 2 |
Prostaglandin D2 receptor | 0 | 0 | 1 | 1 |
Snq2p | 0 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 2 precursor | 4 | 0 | 0 | 4 |
Sodium-dependent noradrenaline transporter | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 3 | 0 | 2 | 0 | 2 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Envelope glycoprotein | 0 | 0 | 1 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 2B1 | 0 | 4 | 0 | 5 |
Phospholipase A2, major isoenzyme | 0 | 1 | 0 | 1 |
Procathepsin L | 0 | 2 | 2 | 4 |
Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
Indoleamine 2,3-dioxygenase 1 | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP3 subtype | 0 | 1 | 0 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 3 | 0 | 3 |
Prostaglandin E2 receptor EP1 subtype | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 3 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
P53 | 2 | 0 | 0 | 2 |
pyruvate kinase | 2 | 0 | 0 | 2 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 8 | 0 | 0 | 8 |
transcription factor p65 isoform 1 | 0 | 0 | 2 | 2 |
Estrogen receptor beta | 0 | 0 | 2 | 3 |
Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 0 | 2 | 3 |
Endothelin receptor type B | 2 | 0 | 0 | 2 |
Endothelin-1 receptor | 2 | 0 | 0 | 2 |
Survival motor neuron protein | 0 | 0 | 0 | 1 |
Chain B, Pulmonary surfactant-associated protein D | 0 | 1 | 0 | 1 |
Chain A, Pulmonary surfactant-associated protein D | 0 | 1 | 0 | 1 |
Sodium/myo-inositol cotransporter 2 | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 0 | 0 | 0 | 1 |
Retinoic acid receptor alpha | 0 | 1 | 0 | 1 |
Retinoic acid receptor gamma | 0 | 1 | 0 | 1 |
Retinoic acid receptor beta | 0 | 1 | 0 | 1 |
Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 1 | 0 | 2 | 0 | 2 |
Retinoic acid receptor RXR-alpha | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-beta | 0 | 1 | 0 | 1 |
Retinoic acid receptor RXR-gamma | 0 | 1 | 0 | 1 |
Cellular retinoic acid-binding protein 1 | 0 | 1 | 0 | 1 |
Cellular retinoic acid-binding protein 1 | 0 | 0 | 1 | 1 |
Olfactory receptor 51E2 | 0 | 1 | 1 | 2 |
Chymotrypsinogen A | 0 | 4 | 0 | 4 |
Cell division control protein 42 homolog | 0 | 1 | 0 | 1 |
Ras-related C3 botulinum toxin substrate 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 1B1 | 0 | 6 | 1 | 7 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Large neutral amino acids transporter small subunit 1 | 0 | 3 | 0 | 3 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 8 | 2 | 10 |
Replicase polyprotein 1ab | 0 | 1 | 2 | 3 |
CAAX prenyl protease 2 isoform 2 | 0 | 0 | 0 | 1 |
Tubulin beta-4A chain | 0 | 1 | 0 | 1 |
Tubulin beta chain | 0 | 1 | 0 | 1 |
Tubulin alpha-3C chain | 0 | 1 | 0 | 1 |
Tubulin alpha-1B chain | 0 | 1 | 0 | 1 |
Tubulin alpha-4A chain | 0 | 1 | 0 | 1 |
Tubulin beta-4B chain | 0 | 1 | 0 | 1 |
DNA primase | 0 | 1 | 0 | 1 |
Tubulin beta-3 chain | 0 | 1 | 0 | 1 |
Tubulin beta-2A chain | 0 | 1 | 0 | 1 |
Tubulin beta-8 chain | 0 | 1 | 0 | 1 |
Tubulin alpha-3E chain | 0 | 1 | 0 | 1 |
Tubulin alpha-1A chain | 0 | 1 | 0 | 1 |
Tubulin alpha-1C chain | 0 | 1 | 0 | 1 |
Tubulin beta-6 chain | 0 | 1 | 0 | 1 |
Tubulin beta-2B chain | 0 | 1 | 0 | 1 |
Tubulin beta-1 chain | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily A member 5 | 0 | 2 | 0 | 2 |
Potassium voltage-gated channel subfamily D member 2 | 0 | 2 | 0 | 2 |
Chain A, Antigen Cd11a (p180) | 0 | 1 | 0 | 1 |
isocitrate dehydrogenase 1, partial | 2 | 0 | 0 | 2 |
bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
Integrin beta-2 | 0 | 1 | 0 | 1 |
Intercellular adhesion molecule 1 | 0 | 1 | 0 | 1 |
Neutrophil elastase | 0 | 3 | 0 | 3 |
Insulin receptor | 0 | 1 | 0 | 1 |
Integrin alpha-L | 0 | 1 | 1 | 2 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
Acyl-CoA:cholesterol acyltransferase | 0 | 1 | 0 | 1 |
Replicase polyprotein 1a | 0 | 0 | 3 | 3 |
ClpP | 2 | 0 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 2 | 0 | 4 |
Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 5 | 1 | 6 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Melatonin receptor type 1A | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 0 | 1 | 1 |
Melatonin receptor type 1A | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 2 | 1 | 3 |
Melatonin receptor type 1C | 0 | 1 | 1 | 2 |
Melatonin receptor type 1B | 0 | 1 | 1 | 2 |
Carboxylic ester hydrolase | 0 | 1 | 0 | 1 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Secreted chorismate mutase | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily M member 8 | 0 | 1 | 2 | 4 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 0 | 1 | 1 |
Transient receptor potential cation channel subfamily M member 8 | 0 | 0 | 1 | 1 |
microphthalmia-associated transcription factor isoform 9 | 0 | 1 | 0 | 1 |
Tumor necrosis factor | 0 | 2 | 0 | 2 |
Neuraminidase | 0 | 1 | 0 | 1 |
Platelet-activating factor receptor | 1 | 0 | 0 | 1 |
Cystathionine gamma-lyase | 0 | 2 | 0 | 2 |
Protein-arginine deiminase type-4 | 0 | 1 | 0 | 1 |
Cystine/glutamate transporter | 0 | 1 | 0 | 1 |
Hydroxyacid oxidase 1 | 0 | 1 | 0 | 1 |
Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain A, Aminopeptidase | 0 | 1 | 0 | 1 |
Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
S-ribosylhomocysteine lyase | 0 | 1 | 0 | 1 |
Adenylate cyclase type 5 | 0 | 0 | 0 | 1 |
S-adenosylmethionine synthase isoform type-1 | 0 | 0 | 0 | 1 |
S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 0 | 1 |
Fatty acid synthase | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
Beta-1 adrenergic receptor | 0 | 1 | 3 | 5 |
Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
Thioredoxin reductase | 0 | 1 | 0 | 1 |
Flavodoxin | 0 | 0 | 0 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 2 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 1 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 1 | 0 | 1 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Epoxide hydrolase 1 | 0 | 0 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 2 | 0 | 2 |
Aromatase | 0 | 0 | 1 | 1 |
Substance-P receptor | 0 | 4 | 1 | 5 |
Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
Type-2 angiotensin II receptor | 0 | 2 | 0 | 2 |
Beta-lactamase TEM | 0 | 1 | 0 | 1 |
Cytochrome P450 144 | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Steroid C26-monooxygenase | 0 | 0 | 1 | 1 |
Mycocyclosin synthase | 0 | 0 | 1 | 1 |
Lanosterol 14-alpha demethylase | 0 | 0 | 1 | 1 |
Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
Calcium release-activated calcium channel protein 1 | 0 | 1 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 2 |
methionyl-tRNA synthetase, putative | 0 | 1 | 0 | 1 |
Opioid receptor, delta 1b | 0 | 1 | 0 | 1 |
Opioid receptor homologue | 0 | 1 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Histidine decarboxylase | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
BRCA1 | 2 | 0 | 0 | 2 |
Estrogen receptor 1 | 0 | 2 | 0 | 2 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | 0 | 1 | 0 | 1 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 0 | 1 | 0 | 1 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial | 0 | 1 | 0 | 1 |
[Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial | 0 | 1 | 0 | 1 |
Hormone-sensitive lipase | 0 | 1 | 0 | 1 |
Atrial natriuretic peptide receptor 1 | 0 | 1 | 0 | 1 |
Interstitial collagenase | 0 | 3 | 1 | 4 |
Leukotriene A-4 hydrolase | 0 | 2 | 0 | 2 |
STE24 | 0 | 0 | 0 | 1 |
CAAX prenyl protease | 0 | 0 | 0 | 1 |
Chain A, ARGINASE 1 | 0 | 1 | 0 | 1 |
Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
Chain A, ARGINASE 1 | 0 | 1 | 0 | 1 |
Chain A, L-ARGININE\\:GLYCINE AMIDINOTRANSFERASE | 0 | 1 | 0 | 1 |
MBT domain-containing protein 1 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 4 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 3 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 1 | 0 | 1 | 0 | 1 |
Microphthalmia-associated transcription factor | 0 | 0 | 0 | 1 |
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
caspase recruitment domain family, member 15 | 0 | 1 | 0 | 1 |
glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
receptor-interacting serine/threonine-protein kinase 2 isoform 1 | 0 | 1 | 0 | 1 |
Hypoxanthine-guanine phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
Type II pantothenate kinase | 0 | 0 | 0 | 1 |
Type III pantothenate kinase | 0 | 0 | 0 | 1 |
Chain A, cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 1 |
High affinity cAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A | 0 | 2 | 0 | 2 |
Vascular endothelial growth factor receptor 1 | 0 | 1 | 0 | 1 |
Vascular endothelial growth factor receptor 3 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | 0 | 1 | 0 | 1 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 2 | 0 | 2 |
Phosphodiesterase | 0 | 1 | 0 | 1 |
cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 0 | 1 | 0 | 2 |
vasopressin V1b receptor | 1 | 0 | 0 | 1 |
relaxin receptor 1 isoform 1 | 2 | 0 | 0 | 2 |
Arylacetamide deacetylase | 0 | 1 | 0 | 3 |
Arylacetamide deacetylase | 0 | 0 | 0 | 1 |
Arylacetamide deacetylase | 0 | 0 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain B, Penicillin Amidohydrolase | 0 | 1 | 0 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Lysozyme | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
Chain A, Ferritin light chain | 0 | 0 | 2 | 2 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
Gag-Pol polyprotein | 0 | 1 | 0 | 1 |
fMet-Leu-Phe receptor | 0 | 1 | 0 | 1 |
Cyclooxygenase-2 | 0 | 1 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 2 | 2 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 2 | 2 |
interferon gamma precursor | 0 | 0 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 1 | 1 | 2 |
Beta-casein | 0 | 1 | 0 | 1 |
Matrix metalloproteinase-9 | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-1B adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-mannosidase 2C1 | 0 | 0 | 1 | 1 |
Alpha-2B adrenergic receptor | 0 | 1 | 0 | 1 |
3-oxo-5-alpha-steroid 4-dehydrogenase 2 | 0 | 1 | 0 | 1 |
Alpha-2C adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
luciferase | 0 | 0 | 0 | 1 |
Glucocorticoid receptor | 0 | 1 | 1 | 2 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Endothelin-1 receptor | 0 | 1 | 1 | 2 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Type-1 angiotensin II receptor | 0 | 1 | 1 | 2 |
Cholecystokinin receptor type A | 0 | 1 | 1 | 2 |
Vasopressin V1a receptor | 0 | 1 | 1 | 2 |
Beta-2 adrenergic receptor | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 2 group E member 1 | 0 | 0 | 2 | 2 |
Chain A, dATP pyrophosphohydrolase | 0 | 1 | 0 | 1 |
Chain A, Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
Chain B, Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain A, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain B, (3R)-hydroxymyristoyl-acyl carrier protein dehydratase | 0 | 1 | 0 | 1 |
Chain A, APH(2')-Id | 0 | 1 | 0 | 1 |
glucose-6-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
hexokinase | 0 | 2 | 0 | 2 |
Spike glycoprotein | 0 | 0 | 2 | 2 |
galactokinase | 1 | 0 | 0 | 1 |
tyrosine-protein kinase Yes | 1 | 0 | 0 | 1 |
Transmembrane protease serine 2 | 0 | 0 | 2 | 2 |
Maltase-glucoamylase, intestinal | 0 | 1 | 0 | 1 |
NUAK family SNF1-like kinase 1 | 0 | 1 | 0 | 1 |
B2 bradykinin receptor | 0 | 1 | 0 | 1 |
G2/mitotic-specific cyclin-B2 | 0 | 1 | 0 | 1 |
Arginase | 0 | 1 | 0 | 1 |
Pancreatic triacylglycerol lipase | 0 | 1 | 0 | 1 |
Prothrombin | 0 | 1 | 0 | 1 |
Chymotrypsin-like elastase family member 1 | 0 | 1 | 0 | 1 |
Protein E6 | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 2 | 0 | 2 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Glycogen phosphorylase, liver form | 0 | 1 | 0 | 1 |
Epoxide hydrolase 1 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Yes | 0 | 1 | 0 | 1 |
Proto-oncogene tyrosine-protein kinase receptor Ret | 0 | 1 | 0 | 1 |
Insulin-like growth factor 1 receptor | 0 | 1 | 0 | 1 |
72 kDa type IV collagenase | 0 | 1 | 0 | 1 |
Stromelysin-1 | 0 | 1 | 1 | 2 |
Hepatocyte growth factor receptor | 0 | 1 | 0 | 1 |
Heterogeneous nuclear ribonucleoprotein A1 | 0 | 0 | 1 | 1 |
Enoyl-[acyl-carrier-protein] reductase [NADH] FabI | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 0 | 2 | 2 |
Alpha-amylase 1A | 0 | 1 | 0 | 1 |
Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
Sialidase | 0 | 2 | 0 | 2 |
Malate dehydrogenase | 0 | 1 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 2 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 4 | 0 | 1 | 0 | 1 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Cystic fibrosis transmembrane conductance regulator | 0 | 0 | 2 | 2 |
Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
G2/mitotic-specific cyclin-B1 | 0 | 1 | 0 | 1 |
Urease subunit alpha | 0 | 3 | 0 | 3 |
Serine/threonine-protein kinase B-raf | 0 | 1 | 0 | 1 |
G2/mitotic-specific cyclin-B | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 1 | 0 | 1 |
Chymotrypsinogen B | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 3 | 0 | 5 |
Polyunsaturated fatty acid lipoxygenase ALOX12 | 0 | 1 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 4 | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
5'-nucleotidase | 0 | 1 | 0 | 1 |
Glyceraldehyde-3-phosphate dehydrogenase, glycosomal | 0 | 1 | 0 | 1 |
G1/S-specific cyclin-D1 | 0 | 1 | 0 | 1 |
Cytosol aminopeptidase | 0 | 1 | 0 | 1 |
ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | 0 | 2 | 0 | 2 |
Vasopressin V2 receptor | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase receptor UFO | 0 | 1 | 0 | 1 |
RAC-alpha serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
Receptor-type tyrosine-protein kinase FLT3 | 0 | 1 | 0 | 1 |
Macrophage metalloelastase | 0 | 1 | 0 | 1 |
Glutathione reductase | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase SYK | 0 | 1 | 1 | 2 |
Collagenase 3 | 0 | 1 | 0 | 1 |
1-deoxy-D-xylulose 5-phosphate reductoisomerase | 0 | 1 | 0 | 1 |
Prolyl endopeptidase | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
C-C chemokine receptor type 4 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase Nek2 | 0 | 1 | 0 | 1 |
Oligo-1,6-glucosidase IMA1 | 0 | 1 | 0 | 1 |
Death-associated protein kinase 1 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 10 | 0 | 2 | 0 | 2 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Anthrax toxin receptor 2 | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 3 | 0 | 3 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 6 | 0 | 1 | 0 | 1 |
Cyclin-dependent-like kinase 5 | 0 | 1 | 0 | 1 |
Heat shock factor protein 1 | 0 | 1 | 0 | 1 |
Sorbitol dehydrogenase | 0 | 1 | 0 | 1 |
Cyclin homolog | 0 | 1 | 0 | 1 |
cGMP-dependent 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 1 | 0 | 1 |
Focal adhesion kinase 1 | 0 | 1 | 0 | 1 |
Calcium/calmodulin-dependent protein kinase type II subunit beta | 0 | 1 | 0 | 1 |
ELAV-like protein 3 | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 5 activator 1 | 0 | 1 | 0 | 1 |
ELAV-like protein 1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase N1 | 0 | 1 | 0 | 1 |
Probable maltase-glucoamylase 2 | 0 | 1 | 0 | 1 |
Casein kinase II subunit alpha 3 | 0 | 2 | 0 | 2 |
Inositol polyphosphate multikinase | 0 | 1 | 0 | 1 |
G2/mitotic-specific cyclin-B3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C21 | 0 | 2 | 0 | 2 |
Enoyl-acyl-carrier protein reductase | 0 | 2 | 0 | 2 |
3-oxoacyl-acyl-carrier protein reductase | 0 | 1 | 0 | 1 |
Beta-hydroxyacyl-ACP dehydratase precursor (Fatty acid synthesis protein) | 0 | 1 | 0 | 1 |
Chymotrypsin-C | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme 2 | 0 | 0 | 2 | 2 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase Nek6 | 0 | 1 | 0 | 1 |
NADPH oxidase 4 | 0 | 1 | 0 | 1 |
Dipeptidyl peptidase 3 | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 2 | 0 | 1 | 0 | 1 |
Short transient receptor potential channel 5 | 0 | 1 | 0 | 1 |
ALK tyrosine kinase receptor | 0 | 1 | 0 | 1 |
Sialidase-2 | 0 | 1 | 0 | 1 |
Histidine-rich protein PFHRP-II | 0 | 1 | 0 | 1 |
Multidrug resistance protein 1a | 0 | 0 | 0 | 1 |
Lysine-specific demethylase 4E | 0 | 1 | 0 | 1 |
runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
Advanced glycosylation end product-specific receptor | 0 | 0 | 1 | 1 |
Beta-lactamase | 0 | 1 | 0 | 1 |
Advanced glycosylation end product-specific receptor | 0 | 0 | 1 | 1 |
Prolyl 4-hydroxylase, beta polypeptide | 0 | 0 | 0 | 1 |
Estrogen receptor | 0 | 1 | 0 | 1 |
Gastric inhibitory polypeptide receptor | 0 | 1 | 0 | 1 |
Estrogen receptor beta | 0 | 1 | 0 | 1 |
Chain A, Troponin C, slow skeletal and cardiac muscles | 0 | 0 | 1 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
M18 aspartyl aminopeptidase | 0 | 1 | 0 | 1 |
cathepsin L1 | 0 | 1 | 0 | 1 |
FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
Vif | 0 | 2 | 0 | 2 |
serine/threonine-protein kinase 33 isoform a | 0 | 0 | 1 | 1 |
POsterior Segregation | 0 | 0 | 1 | 1 |
Aryl hydrocarbon receptor | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase ABL1 | 0 | 1 | 0 | 2 |
Myc proto-oncogene protein | 0 | 1 | 0 | 2 |
Cathepsin D | 0 | 1 | 0 | 1 |
Luciferin 4-monooxygenase | 0 | 1 | 0 | 1 |
DNA polymerase alpha catalytic subunit | 0 | 1 | 0 | 1 |
Breakpoint cluster region protein | 0 | 1 | 0 | 2 |
Ornithine decarboxylase | 0 | 1 | 0 | 1 |
Protein kinase C alpha type | 0 | 0 | 1 | 1 |
Nuclear factor NF-kappa-B p105 subunit | 0 | 1 | 0 | 1 |
Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Alpha-glucosidase MAL12 | 0 | 1 | 0 | 1 |
Nuclear factor NF-kappa-B p100 subunit | 0 | 1 | 0 | 1 |
Transcription factor p65 | 0 | 1 | 0 | 1 |
Bcl-2-like protein 1 | 0 | 1 | 0 | 1 |
N1L | 0 | 1 | 0 | 1 |
NAD(P)H dehydrogenase [quinone] 1 | 0 | 0 | 0 | 2 |
Tubulin beta-2B chain | 0 | 1 | 0 | 1 |
Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily A member 1 | 0 | 1 | 0 | 1 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
Similar to alpha-tubulin isoform 1 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-2 | 0 | 0 | 1 | 1 |
NAD-dependent protein deacetylase sirtuin-1 | 0 | 0 | 1 | 3 |
Prenyltransferase homolog | 0 | 0 | 0 | 1 |
NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 0 | 0 | 1 | 1 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
NS5 | 0 | 0 | 1 | 1 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 2 | 2 |
Polymerase basic protein 2 | 0 | 0 | 1 | 1 |
RNA-directed RNA polymerase catalytic subunit | 0 | 0 | 1 | 1 |
Polymerase acidic protein | 0 | 0 | 2 | 2 |
Adenosylhomocysteinase | 0 | 0 | 0 | 2 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 0 | 1 | 1 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
NH(3)-dependent NAD(+) synthetase | 0 | 1 | 0 | 1 |
Glutathione S-transferase omega-1 | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
Chain A, Activated Factor Xa Heavy Chain | 0 | 1 | 0 | 1 |
Coagulation factor XII | 0 | 1 | 0 | 1 |
Suppressor of tumorigenicity 14 protein | 0 | 1 | 0 | 1 |
Sphingosine kinase 2 | 0 | 2 | 0 | 2 |
Sphingosine kinase 1 | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 1 | 0 | 1 |
L-lactate dehydrogenase A chain | 0 | 1 | 0 | 1 |
Neuraminidase | 0 | 1 | 0 | 1 |
Neuromedin-U receptor 2 | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, Lysr-type Regulatory Protein | 0 | 0 | 1 | 1 |
Chain A, 146aa long hypothetical transcriptional regulator | 0 | 0 | 1 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain B, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain C, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Chain A, Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Anthranilate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 0 | 1 |
Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 0 | 1 |
5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Substance-K receptor | 0 | 1 | 1 | 2 |
Neuromedin-K receptor | 0 | 1 | 1 | 2 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Growth hormone secretagogue receptor type 1 | 0 | 0 | 1 | 1 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
nonstructural protein 1 | 0 | 1 | 0 | 1 |
protein AF-9 isoform a | 0 | 0 | 0 | 1 |
Complement C5 | 0 | 0 | 1 | 1 |
cAMP-specific 3',5'-cyclic phosphodiesterase 4C | 0 | 1 | 0 | 1 |
DNA-binding protein Ikaros | 0 | 0 | 0 | 1 |
DNA damage-binding protein 1 | 0 | 1 | 1 | 2 |
Ubiquitin-like modifier activating enzyme 2 | 0 | 1 | 0 | 1 |
SUMO1 activating enzyme subunit 1 | 0 | 1 | 0 | 1 |
SUMO-conjugating enzyme UBC9 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4 gamma 1 isoform 4 | 0 | 1 | 0 | 1 |
eukaryotic translation initiation factor 4E isoform 1 | 0 | 1 | 0 | 1 |
Tat | 0 | 1 | 0 | 1 |
bifunctional UDP-N-acetylglucosamine pyrophosphorylase/glucosamine-1-phosphate N-acetyltransferase | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine kinase, cytosolic | 0 | 2 | 0 | 4 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 2 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Protein Rev | 0 | 0 | 1 | 1 |
procathepsin L isoform 1 preproprotein | 0 | 1 | 0 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Chain X, Thyroid hormone receptor beta-1 | 0 | 0 | 1 | 1 |
Thyroid hormone receptor alpha | 0 | 2 | 2 | 4 |
Thyroid hormone receptor beta | 0 | 2 | 2 | 4 |
Proliferating cell nuclear antigen | 0 | 1 | 0 | 1 |
Thyroid hormone receptor beta | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 4C1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 4A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1C1 | 0 | 1 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
Chain A, Arginase 1 | 0 | 1 | 0 | 1 |
D-alanyl-D-alanine dipeptidase | 0 | 1 | 0 | 1 |
Proprotein convertase subtilisin/kexin type 7 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1-like protein 1 | 0 | 1 | 0 | 1 |
Vitamin K epoxide reductase complex subunit 1 | 0 | 2 | 0 | 2 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |